These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6398400)

  • 1. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
    Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
    Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of insulin secretion in the pathogenesis of diabetes mellitus].
    Verlohren HJ; Lohmann D
    Z Gesamte Inn Med; 1981 Feb; 36(4):254-6. PubMed ID: 7013305
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathobiology of the islets of Langerhans.
    Lacy PE
    Proc Inst Med Chic; 1969 May; 27(9):238-45. PubMed ID: 4894231
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraislet negative insulin-glucagon feedback.
    Samols E; Harrison J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1443-7. PubMed ID: 790090
    [No Abstract]   [Full Text] [Related]  

  • 5. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient neonatal diabetes mellitus, type 4, type 1 diabetes mellitus, or MODY: which disease is it, anyway?
    AvRuskin TW; Juan CS
    J Pediatr Endocrinol Metab; 2002 May; 15(5):629-36. PubMed ID: 12014522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.
    Ganda OP; Srikanta S; Brink SJ; Morris MA; Gleason RE; Soeldner JS; Eisenbarth GS
    Diabetes; 1984 Jun; 33(6):516-21. PubMed ID: 6373458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
    Starostina EG; Lobanova AM; Magomedova AK
    Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
    Ammon HP
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1675-6. PubMed ID: 4150009
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effect of tolbutamide on DNA-, protein-, and insulin concentration as well as on insulin secretion of isolated islands of the rat pancreas].
    Schauder P; Frerichs H
    Verh Dtsch Ges Inn Med; 1974; 80():1291-3. PubMed ID: 4616487
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin release during post-tolbutamide glucose test. Its effect in children with decreased insulin reserve.
    Cresto JC; Dujovne IL; Sires JM; Aparicio NJ; De Majo SF
    Medicina (B Aires); 1977; 37(2):133-8. PubMed ID: 331023
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of adenosine triphosphate (ATP) on the secretion of insulin induced by tolbutamide in the absence of glucose].
    Chapal J; Roye M; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1980; 173(6):1120-3. PubMed ID: 6446366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors controlling release of insulin from beta cell in relation to diabetes mellitus.
    Romanoff NE
    N Y State J Med; 1968 Feb; 68(3):385-91. PubMed ID: 4865846
    [No Abstract]   [Full Text] [Related]  

  • 19. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolbutamide stimulation of 45Ca fluxes in microdissected pancreatic islets rich in beta-cells.
    Hellman B
    Mol Pharmacol; 1981 Jul; 20(1):83-8. PubMed ID: 7027024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.